New research published in JAMA Network Open suggests that there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.
Continue Reading this article here
Weight-loss drugs tied to lower death, recurrence risk after breast cancer
